시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 좌골 신경통 치료 시장 규모, 점유율, 성장 분석 : 유형별, 약제 클래스별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)
Sciatica Treatment Market Size, Share, and Growth Analysis, By Type (Acute, Chronic), By Drug Class (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids), By Distribution Channel, By Region - Industry Forecast 2025-2032
상품코드 : 1647511
리서치사 : SkyQuest
발행일 : 2025년 01월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,652,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,951,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,250,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

좌골 신경통 치료 세계 시장 규모는 2023년에 7억 3,474만 달러로 평가되었습니다. 또한, 2024년 7억 6,486만 달러에서 2032년에는 10억 5,485만 달러로 성장할 것으로 예상되며, 예측 기간(2025-2032년) 동안 4.1%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

시장 인사이트에 따르면 좌골신경통은 좌식 생활습관, 비만율 증가, 노령화 등이 큰 영향을 미치며, 좌골신경통 환자가 증가하는 추세에 있습니다. 이 질환은 좌골 신경을 따라 방사통으로 나타나며, 추간판탈출증, 골극, 척추관 협착증과 관련이 있는 경우가 많습니다. 진단 기술의 발전으로 좌골신경통의 식별은 더욱 향상되었고, 그 결과 보고되는 사례는 급증하고 있습니다. 조사에 따르면, 약 40%의 사람들이 좌골신경통을 경험하며, 그 빈도는 40-50세에서 가장 높으며, 여성보다 남성에게 더 많이 발생합니다. 좌골신경통에 대한 인식과 진단이 향상됨에 따라, 좌골신경통의 근본적인 원인을 해결하는 것이 증가하는 환자 집단에 미치는 영향을 관리하는 데 필수적일 것입니다.

목차

서론

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

좌골 신경통 치료 시장 규모 : 유형별

좌골 신경통 치료 시장 규모 : 약제 클래스별

좌골 신경통 치료 시장 규모 : 유통 채널별

좌골 신경통 치료 시장 규모

경쟁 정보

주요 기업 개요

결론과 추천 사항

LSH
영문 목차

영문목차

Global Sciatica Treatment Market size was valued at USD 734.74 million in 2023 and is poised to grow from USD 764.86 million in 2024 to USD 1054.85 million by 2032, growing at a CAGR of 4.1% during the forecast period (2025-2032).

Market insights indicate a rising trend in sciatica cases, largely influenced by sedentary lifestyles, increasing obesity rates, and an aging demographic. This condition manifests as pain radiating along the sciatic nerve, often related to herniated disks, bone spurs, or spinal stenosis. Advancements in diagnostic technologies have further improved the identification of sciatica, resulting in a surge of reported cases. Research shows that around 40% of individuals will experience sciatica at some point, with the highest frequency observed in those aged 40 to 50, and a greater prevalence in men compared to women. As awareness and diagnosis improve, addressing sciatica's underlying causes will be essential for managing its impact on the growing patient population.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sciatica Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Sciatica Treatment Market Segments Analysis

Global Sciatica Treatment Market is segmented by Type, Drug Class, Distribution Channel and region. Based on Type, the market is segmented into Acute, Chronic and Others. Based on Drug Class, the market is segmented into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Antidepressants and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies and Retail & Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Sciatica Treatment Market

The global Sciatica Treatment market is significantly influenced by the high prevalence of sciatica, a condition affecting 10-40% of the population, particularly among older individuals, with a lifetime occurrence rate of up to 43%. This rising incidence of both chronic and acute cases, especially in adults aged 60 and above, where rates soar to 19.2%, drives the demand for effective treatments. While surgical options like microdiscectomy or spinal fusion are available, their high costs present accessibility challenges, particularly in low- and middle-income nations with limited healthcare resources. Emerging treatments, such as stem cell therapy, though promising, may also lack adequate insurance coverage, further complicating patient access to necessary care.

Restraints in the Global Sciatica Treatment Market

The Global Sciatica Treatment market faces significant restraints primarily due to the high costs associated with surgical interventions, such as microdiscectomy and spinal fusion, which are commonly recommended for sciatica relief. Furthermore, emerging therapies like stem cell treatment, despite their potential benefits, also come with increased expenses, and there is uncertainty regarding insurance coverage for these advanced procedures. These financial burdens create substantial barriers, restricting access to various treatment options, especially for patients in low- and middle-income nations where healthcare resources are limited. Ultimately, the economic constraints significantly hinder the ability to seek adequate sciatica care for many individuals.

Market Trends of the Global Sciatica Treatment Market

The Global Sciatica Treatment Market is experiencing significant growth, driven largely by advancements in diagnostic imaging technologies such as MRI and CT scans. These innovations have transformed the identification of sciatica's underlying causes, allowing for faster and more accurate diagnoses, which facilitate timely interventions. Early detection is essential in averting the progression from acute sciatica to chronic, debilitating conditions. Enhanced diagnostic precision empowers healthcare providers to deliver effective treatments promptly, improving patient outcomes and reducing the risk of disability. Additionally, the increasing prevalence of sciatica cases is further propelling market expansion, underscoring the importance of innovative solutions in managing this condition.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Sciatica Treatment Market Size by Type & CAGR (2025-2032)

Global Sciatica Treatment Market Size by Drug Class & CAGR (2025-2032)

Global Sciatica Treatment Market Size by Distribution Channel & CAGR (2025-2032)

Global Sciatica Treatment Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기